Cart
sales@molnova.com
Insulin Receptor 1142-1153
CAS No. 141171-54-2
Insulin Receptor 1142-1153 ( [pTyr1146][pTyr1150][pTyr1151]Insulin Receptor 1142-1153 )
Catalog No. M29958 CAS No. 141171-54-2
[pTyr1146][pTyr1150][pTyr1151]Insulin Receptor (1142-1153) binds to insulin and can be used as insulin receptor tyrosine kinase substrates.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameInsulin Receptor 1142-1153
-
NoteResearch use only, not for human use.
-
Brief Description[pTyr1146][pTyr1150][pTyr1151]Insulin Receptor (1142-1153) binds to insulin and can be used as insulin receptor tyrosine kinase substrates.
-
Description[pTyr1146][pTyr1150][pTyr1151]Insulin Receptor (1142-1153) binds to insulin and can be used as insulin receptor tyrosine kinase substrates.
-
Synonyms[pTyr1146][pTyr1150][pTyr1151]Insulin Receptor 1142-1153
-
PathwayTyrosine Kinase
-
TargetInsulin Receptor
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number141171-54-2
-
Formula Weight1862.7
-
Molecular FormulaC72H110N19O33P3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Shintani T, et al. The R3 receptor-like protein tyrosine phosphatase subfamily inhibits insulin signalling by dephosphorylating the insulin receptor at specific sites. J Biochem. 2015 Sep;158(3):235-43.
molnova catalog
related products
-
Insulin Receptor 114...
[pTyr1146][pTyr1150][pTyr1151]Insulin Receptor (1142-1153) binds to insulin and can be used as insulin receptor tyrosine kinase substrates.
-
MSDC-0160
A new generation insulin sensitizer and mitochondrial target of thiazolidinediones (mTOT) modulator that has low affinity for binding and activation of PPARγ (EC50=23.7 uM).
-
S961
S961 is an high-affinity and selective insulin receptor (IR) antagonist with IC50s of 0.048, 0.027, and 630 nM for HIR-A, HIR-B, and human insulin-like growth factor I receptor (HIGF-IR) in SPA-assay, respectively.
